Study Overview

A double-blind placebo-controlled human clinical to evaluate the ability of XanGo Juice to reduce inflammation levels in overweight persons with inflammation.

Researchers

Jay Udani, MD, CPI is the founder, CEO and Medical Director of Medicus Research. He is a board-certified Internist who served as Chief Resident at Cedars-Sinai Medical Center before completing two fellowships in Health-Services Research and Integrative Medicine at Cedars-Sinai/UCLA. He was one of the first physicians to become a Certified Principal Investigator (CPI) through the APPI/ACRP and as a Key Opinion Leader in the field of Integrative Medicine he has designed and performed over 60 clinical trials, and published over 40 articles and textbook chapters. He is the recipient of many prestigious awards including the 2008 Natural Products Association Clinician of the Year, the AMA National Achievement Award, the Harvard Medical School Pinkney Fellowship in Orthopaedic Research, and was voted Best Physician Specialist and Best Medical Speaker in Los Angeles by the Daily News.

Methods

The study was an 8-week randomized, double-blind, placebo-controlled study with a 2-week washout period for subjects who were currently taking anti-inflammatory or antioxidant products.

The purpose of this study was to evaluate the efficacy of multiple dosages of XanGo Juice compared with placebo in the improvement of inflammation and antioxidant levels in obese patients with a confirmed history of inflammation.

Results

XanGo Juice was shown to reduce certain parameters of inflammation and to improve weight and body fat in an overweight population. These results may have implications in the future prevention of cardiovascular disease and diabetes, but longer studies will be needed to explore the role of inflammation in the reduction of these diseases.

XanGo Juice demonstrated an ability to reduce inflammation (as measured by HS-CRP), at all 3 dosages while the placebo group actually experienced a small increase in the amount of inflammation. HS-CRP decreased in all 3 dosages vs. placebo over the 8 week study with the 9 oz. XanGo Juice group being statistically significant when compared to placebo.

Order your first bottle of juice here

c-reactive_protein-1

Shares
Share This